Biolife solutions, inc. announces change of auditor to grant thornton llp

Bothell, wash. , april 7, 2022 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies (cgt) and the broader biopharma markets, today announced that its audit committee (the "committee") approved the engagement of grant thornton llp ("grant thornton") as the company's new independent registered public accounting firm, effective april 6, 2022.
BLFS Ratings Summary
BLFS Quant Ranking